Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Louis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chromosomes, Human, Pair 19

Procedures

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Phenomena

Single-Stranded Conformational Polymorphism

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gerstner E R; Yip S; Wang D L; Louis D N; Iafrate A J; Batchelor T T
Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.
Gabeau-Lacet Darlene; Engler David; Gupta Sumeet; Scangas George A; Betensky Rebecca A; Barker Fred G; Loeffler Jay S; Louis David N; Mohapatra Gayatry
Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.
Gabeau-Lacet Darlene; Aghi Manish; Betensky Rebecca A; Barker Fred G; Loeffler Jay S; Louis David N
Bone involvement predicts poor outcome in atypical meningioma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Louis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gerstner E R; Yip S; Wang D L; Louis D N; Iafrate A J; Batchelor T T
Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.
Neurology 2009;73(18):1509-10.
2009: Gabeau-Lacet Darlene; Engler David; Gupta Sumeet; Scangas George A; Betensky Rebecca A; Barker Fred G; Loeffler Jay S; Louis David N; Mohapatra Gayatry
Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.
Journal of neuropathology and experimental neurology 2009;68(10):1155-65.
2009: Gabeau-Lacet Darlene; Aghi Manish; Betensky Rebecca A; Barker Fred G; Loeffler Jay S; Louis David N
Bone involvement predicts poor outcome in atypical meningioma.
Journal of neurosurgery 2009;111(3):464-71.
2009: Aghi Manish K; Batchelor Tracy T; Louis David N; Barker Fred G; Curry William T
Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.
Journal of neuro-oncology 2009;93(1):115-20.
2008: Stegh Alexander H; Chin Lynda; Louis David N; DePinho Ronald A
What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator.
Cell cycle (Georgetown, Tex.) 2008;7(18):2833-9.
2008: Mohile Nimish A; Forsyth Peter; Stewart Douglas; Raizer Jeffrey J; Paleologos Nina; Kewalramani Tarun; Louis David N; Cairncross J Gregory; Abrey Lauren E
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
Journal of neuro-oncology 2008;89(2):187-93.
2008: Stegh Alexander H; Kesari Santosh; Mahoney John E; Jenq Harry T; Forloney Kristin L; Protopopov Alexei; Louis David N; Chin Lynda; DePinho Ronald A
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(31):10703-8.
2008: Yip Stephen; Iafrate A John; Louis David N
Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.
Journal of neuropathology and experimental neurology 2008;67(1):1-15.
2008: Cahill Daniel P; Codd Patrick J; Batchelor Tracy T; Curry William T; Louis David N
MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
Clinical neurosurgery 2008;55():165-71.
2007: Furnari Frank B; Fenton Tim; Bachoo Robert M; Mukasa Akitake; Stommel Jayne M; Stegh Alexander; Hahn William C; Ligon Keith L; Louis David N; Brennan Cameron; Chin Lynda; DePinho Ronald A; Cavenee Webster K
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Genes & development 2007;21(21):2683-710.
2007: Betensky Rebecca A; Louis David N; Cairncross J Gregory
Tests of association under misclassification: application to histological sampling in oncology.
Statistics in medicine 2007;26(26):4808-16.
2007: Louis David N; Ohgaki Hiroko; Wiestler Otmar D; Cavenee Webster K; Burger Peter C; Jouvet Anne; Scheithauer Bernd W; Kleihues Paul
The 2007 WHO classification of tumours of the central nervous system.
Acta neuropathologica 2007;114(2):97-109.
2007: Abrey Lauren E; Louis David N; Paleologos Nina; Lassman Andrew B; Raizer Jeffrey J; Mason Warren; Finlay Jonathan; MacDonald David R; DeAngelis Lisa M; Cairncross J Gregory;
Survey of treatment recommendations for anaplastic oligodendroglioma.
Neuro-oncology 2007;9(3):314-8.
2007: Cahill Daniel P; Levine Kymberly K; Betensky Rebecca A; Codd Patrick J; Romany Candice A; Reavie Linsey B; Batchelor Tracy T; Futreal P Andrew; Stratton Michael R; Curry William T; Iafrate A John; Louis David N
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2038-45.
2007: Ligon Keith L; Huillard Emmanuelle; Mehta Shwetal; Kesari Santosh; Liu Hongye; Alberta John A; Bachoo Robert M; Kane Michael; Louis David N; Depinho Ronald A; Anderson David J; Stiles Charles D; Rowitch David H
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
Neuron 2007;53(4):503-17.
2007: Batchelor Tracy T; Sorensen A Gregory; di Tomaso Emmanuelle; Zhang Wei-Ting; Duda Dan G; Cohen Kenneth S; Kozak Kevin R; Cahill Daniel P; Chen Poe-Jou; Zhu Mingwang; Ancukiewicz Marek; Mrugala Maciej M; Plotkin Scott; Drappatz Jan; Louis David N; Ivy Percy; Scadden David T; Benner Thomas; Loeffler Jay S; Wen Patrick Y; Jain Rakesh K
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Cancer cell 2007;11(1):83-95.
2007: Stegh Alexander H; Kim Hyunggee; Bachoo Robert M; Forloney Kristin L; Zhang Jean; Schulze Harald; Park Kevin; Hannon Gregory J; Yuan Junying; Louis David N; DePinho Ronald A; Chin Lynda
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.
Genes & development 2007;21(1):98-111.
2007: Mueller W; Nutt C L; Ehrich M; Riemenschneider M J; von Deimling A; van den Boom D; Louis D N
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma.
Oncogene 2007;26(4):583-93.
2006: Mizoguchi Masahiro; Betensky Rebecca A; Batchelor Tracy T; Bernay Derek C; Louis David N; Nutt Catherine L
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Journal of neuropathology and experimental neurology 2006;65(12):1181-8.
2006: Rousseau Audrey; Nutt Catherine L; Betensky Rebecca A; Iafrate A John; Han Moonjoo; Ligon Keith L; Rowitch David H; Louis David N
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Journal of neuropathology and experimental neurology 2006;65(12):1149-56.
2006: Maher Elizabeth A; Brennan Cameron; Wen Patrick Y; Durso Laura; Ligon Keith L; Richardson Aaron; Khatry Deepak; Feng Bin; Sinha Raktim; Louis David N; Quackenbush John; Black Peter McL; Chin Lynda; DePinho Ronald A
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.
Cancer research 2006;66(23):11502-13.
2006: Iliopoulos Othon; Chan-Smutko Gayun; Gonzalez R Gilberto; Louis David N; Stone James R
Case records of the Massachusetts General Hospital. Case 23-2006. A 36-year-old man with numbness in the left [corrected] hand and hypertension.
The New England journal of medicine 2006;355(4):394-402.
2006: Sequist Lecia V; Joshi Victoria A; Jänne Pasi A; Bell Daphne W; Fidias Panos; Lindeman Neal I; Louis David N; Lee Jeffrey C; Mark Eugene J; Longtine Janina; Verlander Peter; Kucherlapati Raju; Meyerson Matthew; Haber Daniel A; Johnson Bruce E; Lynch Thomas J
Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 2):4403s-4408s.
2006: Engler David A; Mohapatra Gayatry; Louis David N; Betensky Rebecca A
A pseudolikelihood approach for simultaneous analysis of array comparative genomic hybridizations.
Biostatistics (Oxford, England) 2006;7(3):399-421.
2006: Riemenschneider Markus J; Betensky Rebecca A; Pasedag Saskia M; Louis David N
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.
Cancer research 2006;66(11):5618-23.
2006: Mohapatra Gayatry; Betensky Rebecca A; Miller Ezra R; Carey Bjorn; Gaumont Leah D; Engler David A; Louis David N
Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization.
The Journal of molecular diagnostics : JMD 2006;8(2):268-76.
2006: Louis David N
Molecular pathology of malignant gliomas.
Annual review of pathology 2006;1():97-117.
2005: Aghi Manish; Gaviani Paola; Henson John W; Batchelor Tracy T; Louis David N; Barker Fred G
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8600-5.
2005: Dong Shumin; Nutt Catherine L; Betensky Rebecca A; Stemmer-Rachamimov Anat O; Denko Nicholas C; Ligon Keith L; Rowitch David H; Louis David N
Histology-based expression profiling yields novel prognostic markers in human glioblastoma.
Journal of neuropathology and experimental neurology 2005;64(11):948-55.
2005: Riemenschneider Markus J; Mueller Wolf; Betensky Rebecca A; Mohapatra Gayatry; Louis David N
In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.
The American journal of pathology 2005;167(5):1379-87.
2005: Shih Helen A; Betensky Rebecca A; Dorfman Molly V; Louis David N; Loeffler Jay S; Batchelor Tracy T
Genetic analyses for predictors of radiation response in glioblastoma.
International journal of radiation oncology, biology, physics 2005;63(3):704-10.
2005: Henson John W; Hobbs Wendy; Chakravarti Arnab; Louis David N
Alterations in p53, p21, and MIB-1 labeling index in primary human astrocytomas following radiation therapy.
Journal of neuro-oncology 2005;74(2):151-4.
2005: Mueller Wolf; Mizoguchi Masahiro; Silen Erica; D'Amore Katrina; Nutt Catherine L; Louis David N
Mutations of the PIK3CA gene are rare in human glioblastoma.
Acta neuropathologica 2005;109(6):654-5.
2005: Betensky Rebecca A; Nutt Catherine L; Batchelor Tracy T; Louis David N
Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.
The Journal of molecular diagnostics : JMD 2005;7(2):276-82.
2005: Riemenschneider Markus J; Bell Daphne W; Haber Daniel A; Louis David N
Pulmonary adenocarcinomas with mutant epidermal growth factor receptors.
The New England journal of medicine 2005;352(16):1724-5.
2005: Nutt Catherine L; Betensky Rebecca A; Brower Melissa A; Batchelor Tracy T; Louis David N; Stemmer-Rachamimov Anat O
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2258-64.
2005: Voloschin Alfredo D; Louis David N; Cosgrove Garth R; Batchelor Tracy T
Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: case study.
Neuro-oncology 2005;7(1):97-100.
2004: Mizoguchi Masahiro; Nutt Catherine L; Mohapatra Gayatry; Louis David N
Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.
Brain pathology (Zurich, Switzerland) 2004;14(4):372-7.
2004: Eskandar Emad N; Loeffler Jay S; O'Neill Alison M; Hunter George J; Louis David N
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion.
The New England journal of medicine 2004;351(18):1875-82.
2004: Mrak Robert E; Yasargil M Gazi; Mohapatra Gayatry; Earel James; Louis David N
Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss.
Human pathology 2004;35(9):1156-9.
2004: Megyesi Joseph F; Kachur Edward; Lee Donald H; Zlatescu Magdalena C; Betensky Rebecca A; Forsyth Peter A; Okada Yoshifumi; Sasaki Hikaru; Mizoguchi Masahiro; Louis David N; Cairncross J Gregory
Imaging correlates of molecular signatures in oligodendrogliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4303-6.
2004: Kiehl Tim-Rasmus; Kalkanis Steven N; Louis David N
Pigmented central neurocytoma.
Acta neuropathologica 2004;107(6):571-4.
2004: Ligon Keith L; Alberta John A; Kho Alvin T; Weiss Jennifer; Kwaan Mary R; Nutt Catherine L; Louis David N; Stiles Charles D; Rowitch David H
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Journal of neuropathology and experimental neurology 2004;63(5):499-509.
2004: Stemmer-Rachamimov Anat O; Louis David N; Nielsen Gunnlaugur P; Antonescu Cristina R; Borowsky Alexander D; Bronson Roderick T; Burns Dennis K; Cervera Pascale; McLaughlin Margaret E; Reifenberger Guido; Schmale Michael C; MacCollin Mia; Chao Richard C; Cichowski Karen; Kalamarides Michel; Messerli Shanta M; McClatchey Andrea I; Niwa-Kawakita Michiko; Ratner Nancy; Reilly Karlyne M; Zhu Yuan; Giovannini Marco
Comparative pathology of nerve sheath tumors in mouse models and humans.
Cancer research 2004;64(10):3718-24.
2004: Lynch Thomas J; Bell Daphne W; Sordella Raffaella; Gurubhagavatula Sarada; Okimoto Ross A; Brannigan Brian W; Harris Patricia L; Haserlat Sara M; Supko Jeffrey G; Haluska Frank G; Louis David N; Christiani David C; Settleman Jeff; Haber Daniel A
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
The New England journal of medicine 2004;350(21):2129-39.
2004: Batchelor Tracy T; Betensky Rebecca A; Esposito J Matthew; Pham Loc-Duyen D; Dorfman Molly V; Piscatelli Nicole; Jhung Sarah; Rhee David; Louis David N
Age-dependent prognostic effects of genetic alterations in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):228-33.
2003: Deisboeck T S; Wakimoto H; Nestler U; Louis D N; Sehgal P K; Simon M; Chiocca E A; Hochberg F H
Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study.
Gene therapy 2003;10(15):1225-33.
2003: Kohane Daniel S; Smith Sarah E; Louis David N; Colombo Gaia; Ghoroghchian Peter; Hunfeld Nicole G M; Berde Charles B; Langer Robert
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres.
Pain 2003;104(1-2):415-21.
2003: MacCollin M; Willett C; Heinrich B; Jacoby L B; Acierno J S; Perry A; Louis D N
Familial schwannomatosis: exclusion of the NF2 locus as the germline event.
Neurology 2003;60(12):1968-74.
2003: Hampl Jürgen A; Camp Sara M; Mydlarz Wojciech K; Hampl Monika; Ichikawa Tomotsuga; Chiocca E Antonio; Louis David N; Sena-Esteves Miguel; Breakefield Xandra O
Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors.
Human gene therapy 2003;14(7):611-26.
2003: Betensky Rebecca A; Louis David N; Cairncross J Gregory
Analysis of a molecular genetic neuro-oncology study with partially biased selection.
Biostatistics (Oxford, England) 2003;4(2):167-78.
2003: Nutt Catherine L; Mani D R; Betensky Rebecca A; Tamayo Pablo; Cairncross J Gregory; Ladd Christine; Pohl Ute; Hartmann Christian; McLaughlin Margaret E; Batchelor Tracy T; Black Peter M; von Deimling Andreas; Pomeroy Scott L; Golub Todd R; Louis David N
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Cancer research 2003;63(7):1602-7.
2003: Braaten Kristina M; Betensky Rebecca A; de Leval Laurence; Okada Yoshifumi; Hochberg Fred H; Louis David N; Harris Nancy L; Batchelor Tracy T
BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1063-9.
2003: Heinrich Bianca; Hartmann Christian; Stemmer-Rachamimov Anat O; Louis David N; MacCollin Mia
Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms.
International journal of cancer. Journal international du cancer 2003;103(4):483-8.
2003: Okada Yoshifumi; Hurwitz Edward E; Esposito John M; Brower Melissa A; Nutt Catherine L; Louis David N
Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
Cancer research 2003;63(2):413-6.
2002: Lam Paula; Hui Kam M; Wang Yaming; Allen Paul D; Louis David N; Yuan C J; Breakefield Xandra O
Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors.
Human gene therapy 2002;13(18):2147-59.
2002: Rabinov James D; Lee Patricia Lani; Barker Frederick G; Louis David N; Harsh Griffith R; Cosgrove G Rees; Chiocca E Antonio; Thornton Allan F; Loeffler Jay S; Henson John W; Gonzalez R Gilberto
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.
Radiology 2002;225(3):871-9.
2002: Weiss William A; Israel Mark; Cobbs Charles; Holland Eric; James C David; Louis David N; Marks Cheryl; McClatchey Andrea I; Roberts Tim; Van Dyke Terry; Wetmore Cynthia; Chiu Ing-Ming; Giovannini Marco; Guha Abhijit; Higgins Robert J; Marino Silvia; Radovanovic Ivan; Reilly Karlyne; Aldape Ken
Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
Oncogene 2002;21(49):7453-63.
2002: Hartmann Christian; Johnk Loki; Kitange Gaspar; Wu Yanhong; Ashworth Linda K; Jenkins Robert B; Louis David N
Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.
Cancer research 2002;62(14):4100-8.
2002: Okada Yoshifumi; Nishikawa Ryo; Matsutani Masao; Louis David N
Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors.
Journal of neuropathology and experimental neurology 2002;61(6):531-8.
2002: Betensky Rebecca A; Louis David N; Cairncross J Gregory
Influence of unrecognized molecular heterogeneity on randomized clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2495-9.
2002: Bachoo Robert M; Maher Elizabeth A; Ligon Keith L; Sharpless Norman E; Chan Suzanne S; You Mingjian James; Tang Yi; DeFrances Jessica; Stover Elizabeth; Weissleder Ralph; Rowitch David H; Louis David N; DePinho Ronald A
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.
Cancer cell 2002;1(3):269-77.
2002: Hartmann Christian; Johnk Loki; Sasaki Hikaru; Jenkins Robert B; Louis David N
Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.
Brain pathology (Zurich, Switzerland) 2002;12(2):178-82.
2002: Louis David N; Pomeroy Scott L; Cairncross J Gregory
Focus on central nervous system neoplasia.
Cancer cell 2002;1(2):125-8.
2002: Sasaki Hikaru; Betensky Rebecca A; Cairncross J Gregory; Louis David N
DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
Cancer research 2002;62(6):1790-6.
2002: Li Yi; Betensky Rebecca A; Louis David N; Cairncross J Gregory
The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power.
Biometrics 2002;58(1):232-6.
2002: Kohane Daniel S; Lipp Michael; Kinney Ramsey C; Anthony Douglas C; Louis David N; Lotan Noah; Langer Robert
Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Journal of biomedical materials research 2002;59(3):450-9.
2002: Sasaki Hikaru; Zlatescu Magdalena C; Betensky Rebecca A; Johnk Loki B; Cutone Andrea N; Cairncross J Gregory; Louis David N
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".
Journal of neuropathology and experimental neurology 2002;61(1):58-63.
2002: Pomeroy Scott L; Tamayo Pablo; Gaasenbeek Michelle; Sturla Lisa M; Angelo Michael; McLaughlin Margaret E; Kim John Y H; Goumnerova Liliana C; Black Peter M; Lau Ching; Allen Jeffrey C; Zagzag David; Olson James M; Curran Tom; Wetmore Cynthia; Biegel Jaclyn A; Poggio Tomaso; Mukherjee Shayan; Rifkin Ryan; Califano Andrea; Stolovitzky Gustavo; Louis David N; Mesirov Jill P; Lander Eric S; Golub Todd R
Prediction of central nervous system embryonal tumour outcome based on gene expression.
Nature 2002;415(6870):436-42.
2002: Smith Edward R; Ott Mark; Wain John; Louis David N; Chiocca E Antonio
Massive growth of a meningioma into the brachial plexus and thoracic cavity after intraspinal and supraclavicular resection. Case report and review of the literature.
Journal of neurosurgery 2002;96(1 Suppl):107-11.
2001: Primavera J; Nikas D C; Zamani A A; Shafman T; Alexander E; De Girolami U; Louis D N
Clear cell pleomorphic xanthoastrocytoma: case report.
Acta neuropathologica 2001;102(4):404-8.
2001: Zlatescu M C; TehraniYazdi A; Sasaki H; Megyesi J F; Betensky R A; Louis D N; Cairncross J G
Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.
Cancer research 2001;61(18):6713-5.
2001: Louis D N; Holland E C; Cairncross J G
Glioma classification: a molecular reappraisal.
The American journal of pathology 2001;159(3):779-86.
2001: Lu Q R; Park J K; Noll E; Chan J A; Alberta J; Yuk D; Alzamora M G; Louis D N; Stiles C D; Rowitch D H; Black P M
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(19):10851-6.
2001: Niida Y; Stemmer-Rachamimov A O; Logrip M; Tapon D; Perez R; Kwiatkowski D J; Sims K; MacCollin M; Louis D N; Ramesh V
Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
American journal of human genetics 2001;69(3):493-503.
2001: Dai C; Celestino J C; Okada Y; Louis D N; Fuller G N; Holland E C
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Genes & development 2001;15(15):1913-25.
2001: Sasaki H; Zlatescu M C; Betensky R A; Ino Y; Cairncross J G; Louis D N
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
The American journal of pathology 2001;159(1):359-67.
2001: Maher E A; Furnari F B; Bachoo R M; Rowitch D H; Louis D N; Cavenee W K; DePinho R A
Malignant glioma: genetics and biology of a grave matter.
Genes & development 2001;15(11):1311-33.
2001: Ino Y; Betensky R A; Zlatescu M C; Sasaki H; Macdonald D R; Stemmer-Rachamimov A O; Ramsay D A; Cairncross J G; Louis D N
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):839-45.
2001: Murthy V; Stemmer-Rachamimov A O; Haddad L A; Roy J E; Cutone A N; Beauchamp R L; Smith N; Louis D N; Ramesh V
Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
Acta neuropathologica 2001;101(3):202-10.
2001: Stemmer-Rachamimov A O; Wiederhold T; Nielsen G P; James M; Pinney-Michalowski D; Roy J E; Cohen W A; Ramesh V; Louis D N
NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas.
The American journal of pathology 2001;158(1):57-62.
2000: Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis D N; Henson J W
Molecular genetics of radiographically defined de novo glioblastoma multiforme.
Neuropathology and applied neurobiology 2000;26(6):544-52.
2000: Bauman G S; Ino Y; Ueki K; Zlatescu M C; Fisher B J; Macdonald D R; Stitt L; Louis D N; Cairncross J G
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
International journal of radiation oncology, biology, physics 2000;48(3):825-30.
2000: Chan A W; Tarbell N J; Black P M; Louis D N; Frosch M P; Ancukiewicz M; Chapman P; Loeffler J S
Adult medulloblastoma: prognostic factors and patterns of relapse.
Neurosurgery 2000;47(3):623-31; discussion 631-2.
2000: Misdraji J; Ino Y; Louis D N; Rosenberg A E; Chiocca E A; Harris N L
Primary lymphoma of peripheral nerve: report of four cases.
The American journal of surgical pathology 2000;24(9):1257-65.
2000: Smith J S; Tachibana I; Lee H K; Qian J; Pohl U; Mohrenweiser H W; Borell T J; Hosek S M; Soderberg C L; von Deimling A; Perry A; Scheithauer B W; Louis D N; Jenkins R B
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.
Genes, chromosomes & cancer 2000;29(1):16-25.
2000: Ino Y; Zlatescu M C; Sasaki H; Macdonald D R; Stemmer-Rachamimov A O; Jhung S; Ramsay D A; von Deimling A; Louis D N; Cairncross J G
Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Journal of neurosurgery 2000;92(6):983-90.
2000: Harsh G R; Deisboeck T S; Louis D N; Hilton J; Colvin M; Silver J S; Qureshi N H; Kracher J; Finkelstein D; Chiocca E A; Hochberg F H
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
Journal of neurosurgery 2000;92(5):804-11.
2000: Ikeda K; Wakimoto H; Ichikawa T; Jhung S; Hochberg F H; Louis D N; Chiocca E A
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
Journal of virology 2000;74(10):4765-75.
2000: Qureshi N H; Bankiewicz K S; Louis D N; Hochberg F H; Chiocca E A; Harsh G R
Multicolumn infusion of gene therapy cells into human brain tumors: technical report.
Neurosurgery 2000;46(3):663-8; discussion 668-9.
2000: Smith J S; Tachibana I; Pohl U; Lee H K; Thanarajasingam U; Portier B P; Ueki K; Ramaswamy S; Billings S J; Mohrenweiser H W; Louis D N; Jenkins R B
A transcript map of the chromosome 19q-arm glioma tumor suppressor region.
Genomics 2000;64(1):44-50.
2000: Pohl U; Smith J S; Tachibana I; Ueki K; Lee H K; Ramaswamy S; Wu Q; Mohrenweiser H W; Jenkins R B; Louis D N
EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins.
Genomics 2000;63(2):255-62.
2000: Henson J W; Thornton A F; Louis D N
Spinal cord astrocytoma: response to PCV chemotherapy.
Neurology 2000;54(2):518-20.
1999: Nielsen G P; Stemmer-Rachamimov A O; Ino Y; Moller M B; Rosenberg A E; Louis D N
Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.
The American journal of pathology 1999;155(6):1879-84.
1999: Pohl U; Cairncross J G; Louis D N
Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas.
Brain pathology (Zurich, Switzerland) 1999;9(4):639-43.
1999: Castells A; Ino Y; Louis D N; Ramesh V; Gusella J F; Rustgi A K
Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
Gastroenterology 1999;117(4):831-7.
1999: Peters N; Smith J S; Tachibana I; Lee H K; Pohl U; Portier B P; Louis D N; Jenkins R B
The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss.
Neurogenetics 1999;2(3):163-6.
1999: Nielsen G P; Stemmer-Rachamimov A O; Shaw J; Roy J E; Koh J; Louis D N
Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.
Laboratory investigation; a journal of technical methods and pathology 1999;79(9):1137-43.
1999: Ino Y; Silver J S; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis D N
Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
Journal of neuropathology and experimental neurology 1999;58(8):881-5.
1999: Ikeda K; Ichikawa T; Wakimoto H; Silver J S; Deisboeck T S; Finkelstein D; Harsh G R; Louis D N; Bartus R T; Hochberg F H; Chiocca E A
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.
Nature medicine 1999;5(8):881-7.
1999: Taylor M D; Perry J; Zlatescu M C; Stemmer-Rachamimov A O; Ang L C; Ino Y; Schwartz M; Becker L E; Louis D N; Cairncross J G
The hPMS2 exon 5 mutation and malignant glioma. Case report.
Journal of neurosurgery 1999;90(5):946-50.
1999: Perry J R; Louis D N; Cairncross J G
Current treatment of oligodendrogliomas.
Archives of neurology 1999;56(4):434-6.
1998: Stemmer-Rachamimov A O; Nielsen G P; Rosenberg A E; Louis D N; Jones D; Ramesh V; Gusella J F; Jacoby L B
The NF2 gene and merlin protein in human osteosarcomas.
Neurogenetics 1998;2(1):73-4.
1998: Stemmer-Rachamimov A O; Ino Y; Lim Z Y; Jacoby L B; MacCollin M; Gusella J F; Ramesh V; Louis D N
Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Journal of neuropathology and experimental neurology 1998;57(12):1164-7.
1998: Cairncross J G; Ueki K; Zlatescu M C; Lisle D K; Finkelstein D M; Hammond R R; Silver J S; Stark P C; Macdonald D R; Ino Y; Ramsay D A; Louis D N
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
Journal of the National Cancer Institute 1998;90(19):1473-9.
1998: Nielsen G P; Burns K L; Rosenberg A E; Louis D N
CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
The American journal of pathology 1998;153(1):159-63.
1998: Herrlinger U; Kramm C M; Aboody-Guterman K S; Silver J S; Ikeda K; Johnston K M; Pechan P A; Barth R F; Finkelstein D; Chiocca E A; Louis D N; Breakefield X O
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
Gene therapy 1998;5(6):809-19.
1998: Ohh M; Yauch R L; Lonergan K M; Whaley J M; Stemmer-Rachamimov A O; Louis D N; Gavin B J; Kley N; Kaelin W G; Iliopoulos O
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.
Molecular cell 1998;1(7):959-68.
1998: Cheng L L; Chang I W; Louis D N; Gonzalez R G
Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
Cancer research 1998;58(9):1825-32.
1998: Husain N; Chiocca E A; Rainov N; Louis D N; Zervas N T
Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.
Acta neuropathologica 1998;95(3):287-90.
1998: Burns K L; Ueki K; Jhung S L; Koh J; Louis D N
Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
Journal of neuropathology and experimental neurology 1998;57(2):122-30.
1997: Stemmer-Rachamimov A O; Xu L; Gonzalez-Agosti C; Burwick J A; Pinney D; Beauchamp R; Jacoby L B; Gusella J F; Ramesh V; Louis D N
Universal absence of merlin, but not other ERM family members, in schwannomas.
The American journal of pathology 1997;151(6):1649-54.
1997: Mason W; Louis D N; Cairncross J G
Chemosensitive gliomas in adults: which ones and why?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3423-6.
1997: Chung D C; Smith A P; Louis D N; Graeme-Cook F; Warshaw A L; Arnold A
Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours.
Clinical endocrinology 1997;47(5):523-8.
1997: Herrlinger U; Kramm C M; Johnston K M; Louis D N; Finkelstein D; Reznikoff G; Dranoff G; Breakefield X O; Yu J S
Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
Cancer gene therapy 1997;4(6):345-52.
1997: Chung D C; Smith A P; Louis D N; Graeme-Cook F; Warshaw A L; Arnold A
A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
The Journal of clinical investigation 1997;100(2):404-10.
1997: Stemmer-Rachamimov A O; Gonzalez-Agosti C; Xu L; Burwick J A; Beauchamp R; Pinney D; Louis D N; Ramesh V
Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
Journal of neuropathology and experimental neurology 1997;56(6):735-42.
1997: Ueki K; Ramaswamy S; Billings S J; Mohrenweiser H W; Louis D N
ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3.
Neurogenetics 1997;1(1):31-6.
1997: Ueki K; Ramaswamy S; Billings S J; Mohrenweiser H W; Louis D N
Chromosomal localization to 19q13.3, partial genomic structure and 5' cDNA sequence of the human symplekin gene.
Somatic cell and molecular genetics 1997;23(3):229-31.
1997: Jones R M; MacDonald M E; Branda J; Altherr M R; Louis D N; Schmidt E V
Assignment of the human gene encoding eukaryotic initiation factor 4E (EIF4E) to the region q21-25 on chromosome 4.
Somatic cell and molecular genetics 1997;23(3):221-3.
1997: Stemmer-Rachamimov A O; Louis D N
Histopathologic and immunohistochemical prognostic factors in malignant gliomas.
Current opinion in oncology 1997;9(3):230-4.
1996: Rosenberg J E; Lisle D K; Burwick J A; Ueki K; von Deimling A; Mohrenweiser H W; Louis D N
Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval.
Oncogene 1996;13(11):2483-5.
1996: Platten M; Giordano M J; Dirven C M; Gutmann D H; Louis D N
Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
The American journal of pathology 1996;149(2):621-7.
1996: Chou D; Miyashita T; Mohrenweiser H W; Ueki K; Kastury K; Druck T; von Deimling A; Huebner K; Reed J C; Louis D N
The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas.
Cancer genetics and cytogenetics 1996;88(2):136-40.
1996: Rainov N G; Kramm C M; Aboody-Guterman K; Chase M; Ueki K; Louis D N; Harsh G R; Chiocca A; Breakefield X O
Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Cancer gene therapy 1996;3(2):99-106.
1996: Ueki K; Ono Y; Henson J W; Efird J T; von Deimling A; Louis D N
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Cancer research 1996;56(1):150-3.
1996: Paulus W; Lisle D K; Tonn J C; Wolf H K; Roggendorf W; Reeves S A; Louis D N
Molecular genetic alterations in pleomorphic xanthoastrocytoma.
Acta neuropathologica 1996;91(3):293-7.
1996: Ono Y; Ueki K; Joseph J T; Louis D N
Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas.
Acta neuropathologica 1996;91(3):221-5.
1995: Joseph J T; Lisle D K; Jacoby L B; Paulus W; Barone R; Cohen M L; Roggendorf W H; Bruner J M; Gusella J F; Louis D N
NF2 gene analysis distinguishes hemangiopericytoma from meningioma.
The American journal of pathology 1995;147(5):1450-5.
1995: Louis D N; Gusella J F
A tiger behind many doors: multiple genetic pathways to malignant glioma.
Trends in genetics : TIG 1995;11(10):412-5.
1995: Yong W H; Ueki K; Chou D; Reeves S A; von Deimling A; Gusella J F; Mohrenweiser H W; Buckler A J; Louis D N
Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3.
Genomics 1995;29(2):533-6.
1995: Yong W H; Chou D; Ueki K; Harsh G R; von Deimling A; Gusella J F; Mohrenweiser H W; Louis D N
Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112.
Journal of neuropathology and experimental neurology 1995;54(5):622-6.
1995: Weissmann D J; Ferry J A; Harris N L; Louis D N; Delmonico F; Spiro I
Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
American journal of clinical pathology 1995;103(6):748-55.
1995: Tatter S B; Borges L F; Louis D N
Correction: central neurocytomas of the cervical spinal cord.
Journal of neurosurgery 1995;82(4):706.
1995: Alderson L M; Castleberg R L; Harsh G R; Louis D N; Henson J W
Human gliomas with wild-type p53 express bcl-2.
Cancer research 1995;55(5):999-1001.
1995: Reeves S A; Rubio M P; Louis D N
General method for PCR amplification and direct sequencing of mRNA differential display products.
BioTechniques 1995;18(1):18-20.
1994: Henson J W; Schnitker B L; Correa K M; von Deimling A; Fassbender F; Xu H J; Benedict W F; Yandell D W; Louis D N
The retinoblastoma gene is involved in malignant progression of astrocytomas.
Annals of neurology 1994;36(5):714-21.
1994: Ueki K; Richardson E P; Henson J W; Louis D N
In situ polymerase chain reaction demonstration of JC virus in progressive multifocal leukoencephalopathy, including an index case.
Annals of neurology 1994;36(4):670-3.
1994: Tatter S B; Ogilvy C S; Golden J A; Ojemann R G; Louis D N
Third ventricular xanthogranulomas clinically and radiologically mimicking colloid cysts. Report of two cases.
Journal of neurosurgery 1994;81(4):605-9.
1994: Xu L; Sgroi D; Sterner C J; Beauchamp R L; Pinney D M; Keel S; Ueki K; Rutter J L; Buckler A J; Louis D N
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
Cancer research 1994;54(20):5262-4.
1994: Ueki K; Rubio M P; Ramesh V; Correa K M; Rutter J L; von Deimling A; Buckler A J; Gusella J F; Louis D N
MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
Human molecular genetics 1994;3(10):1841-5.
1994: Rubio M P; Correa K M; Ueki K; Mohrenweiser H W; Gusella J F; von Deimling A; Louis D N
The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.
Cancer research 1994;54(17):4760-3.
1994: Tatter S B; Borges L F; Louis D N
Central neurocytomas of the cervical spinal cord. Report of two cases.
Journal of neurosurgery 1994;81(2):288-93.
1994: MacCollin M; Ramesh V; Jacoby L B; Louis D N; Rubio M P; Pulaski K; Trofatter J A; Short M P; Bove C; Eldridge R
Mutational analysis of patients with neurofibromatosis 2.
American journal of human genetics 1994;55(2):314-20.
1994: Cryns V L; Rubio M P; Thor A D; Louis D N; Arnold A
p53 abnormalities in human parathyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1994;78(6):1320-4.
1994: Jacoby L B; MacCollin M; Louis D N; Mohney T; Rubio M P; Pulaski K; Trofatter J A; Kley N; Seizinger B; Ramesh V
Exon scanning for mutation of the NF2 gene in schwannomas.
Human molecular genetics 1994;3(3):413-9.
1994: Louis D N
The p53 gene and protein in human brain tumors.
Journal of neuropathology and experimental neurology 1994;53(1):11-21.
1994: Rubio M P; Correa K M; Ramesh V; MacCollin M M; Jacoby L B; von Deimling A; Gusella J F; Louis D N
Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Cancer research 1994;54(1):45-7.
1993: Centeno B A; Louis D N; Kupsky W J; Preffer F I; Sobel R A
The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens.
American journal of clinical pathology 1993;100(6):690-6.
1993: Louis D N; Rubio M P; Correa K M; Gusella J F; von Deimling A
Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.
Journal of neuropathology and experimental neurology 1993;52(5):507-15.
1993: Rubio M P; von Deimling A; Yandell D W; Wiestler O D; Gusella J F; Louis D N
Accumulation of wild type p53 protein in human astrocytomas.
Cancer research 1993;53(15):3465-7.
1993: Louis D N; von Deimling A; Chung R Y; Rubio M P; Whaley J M; Eibl R H; Ohgaki H; Wiestler O D; Thor A D; Seizinger B R
Comparative study of p53 gene and protein alterations in human astrocytic tumors.
Journal of neuropathology and experimental neurology 1993;52(1):31-8.
1993: von Deimling A; von Ammon K; Schoenfeld D; Wiestler O D; Seizinger B R; Louis D N
Subsets of glioblastoma multiforme defined by molecular genetic analysis.
Brain pathology (Zurich, Switzerland) 1993;3(1):19-26.
1993: von Deimling A; Louis D N; Menon A G; von Ammon K; Petersen I; Ellison D; Wiestler O D; Seizinger B R
Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
Acta neuropathologica 1993;86(1):81-5.
1992: Louis D N; von Deimling A; Dickersin G R; Dooling E C; Seizinger B R
Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic study.
Human pathology 1992;23(12):1402-9.
1992: Louis D N; von Deimling A; Seizinger B R
A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens.
The American journal of pathology 1992;141(4):777-82.
1992: Ogilvy C S; Louis D N; Ojemann R G
Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological features, and surgical management.
Neurosurgery 1992;31(2):219-29; discussion 229-30.
1992: von Deimling A; von Deimling F; Louis D N; Trofatter J; Gusella J F; Seizinger B R
A RsaI polymorphism in the ERCC2 locus.
Human molecular genetics 1992;1(5):355.
1992: von Deimling A; Louis D N; von Ammon K; Petersen I; Wiestler O D; Seizinger B R
Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
Cancer research 1992;52(15):4277-9.
1992: von Deimling A; Louis D N; von Ammon K; Petersen I; Hoell T; Chung R Y; Martuza R L; Schoenfeld D A; Yasargil M G; Wiestler O D
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
Journal of neurosurgery 1992;77(2):295-301.
1992: von Deimling A; Eibl R H; Ohgaki H; Louis D N; von Ammon K; Petersen I; Kleihues P; Chung R Y; Wiestler O D; Seizinger B R
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
Cancer research 1992;52(10):2987-90.
1991: Louis D N; Hamilton A J; Sobel R A; Ojemann R G
Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report.
Journal of neurosurgery 1991;74(1):129-32.
1991: Louis D N; Edgerton S; Thor A D; Hedley-Whyte E T
Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.
Acta neuropathologica 1991;81(6):675-9.
1990: Louis D N; Swearingen B; Linggood R M; Dickersin G R; Kretschmar C; Bhan A K; Hedley-Whyte E T
Central nervous system neurocytoma and neuroblastoma in adults--report of eight cases.
Journal of neuro-oncology 1990;9(3):231-8.
1990: Steichen J D; Stewart R B; Louis D N; Choi B B; Kung R; Martuza R L
A new 1.9-mu wavelength laser for neurosurgery.
Journal of neurosurgery 1990;73(4):611-4.
1990: Louis D N; Hochberg F H
Cerebral primitive neuroectodermal tumor in an adult, with spinal cord metastasis after 18-year dormancy.
Journal of neuro-oncology 1990;9(1):77-80.
1989: Louis D N; Richardson E P; Dickersin G R; Petrucci D A; Rosenberg A E; Ojemann R G
Primary intracranial leiomyosarcoma. Case report.
Journal of neurosurgery 1989;71(2):279-82.
1989: Louis D N; Hedley-Whyte E T; Martuza R L
Sarcomatous proliferation of the vasculature in a subependymoma.
Acta neuropathologica 1989;78(3):332-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

David Louis

Research Profile (preview)

Disorders

Anatomy

Procedures

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Chemicals & Drugs

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of David Louis (preview)

All Publications